Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review

Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review

ObjectiveThis study aims to delineate the clinical features underlying the concurrent disease of neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (MG), and to identify efficacious therapeutic strategies.BackgroundNMOSD and MG are uncommon autoimmune diseases that infrequently co-...

Cijeli opis

Bibliografski detalji
Glavni autori: Xiaoqian Song, Jingjiao Chen, Chenyang Jin, Yilong Peng, Yuewen Sun, Xueping Zheng
Format: Članak
Jezik:English
Izdano: Frontiers Media S.A. 2025-01-01
Serija:Frontiers in Immunology
Teme:
neuromyelitis optica spectrum disorder
myasthenia gravis
inebilizumab
anti-AQP4 antibodies
anti-acetylcholine receptors antibodies
Online pristup:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1528989/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1528989/full

Slični predmeti